Bayer(US:BAYRY) Zhong Guo Xin Wen Wang·2025-10-09 13:33Group 1: Core Insights - The 8th China International Import Expo (CIIE) is approaching, with companies like Kao and Bayer showcasing their innovations and commitment to the Chinese market [1][2][3] - Kao has localized production for several brands, including Freeplus and Curel, and aims to respond quickly to market changes by moving its global headquarters for Freeplus to China [1][2] - Bayer will present approximately 26 highlight exhibits, including 5 global debuts and 8 China debuts, focusing on innovations in pharmaceuticals, consumer health, and crop science [3][4] Group 2: Company Strategies - Kao's participation emphasizes a "global innovation + local implementation" model, adapting products to meet local agricultural needs and consumer preferences [1][2] - Bayer's strategy includes showcasing advancements in oncology, cardiovascular health, and agricultural innovations, with a focus on integrating global knowledge into local agricultural development [3][4] - Both companies are leveraging the CIIE as a strategic platform to connect with the Chinese market and enhance their brand presence [2][4]